nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Tiotropium—SLC22A4—ulcerative colitis	0.0528	0.356	CrCbGaD
Methylscopolamine bromide—Tiotropium—SLC22A5—ulcerative colitis	0.0397	0.268	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—SLC22A4—ulcerative colitis	0.0277	0.187	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—SLC22A5—ulcerative colitis	0.0208	0.141	CrCbGaD
Methylscopolamine bromide—Mydriasis—Prednisolone—ulcerative colitis	0.0131	0.0202	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Budesonide—ulcerative colitis	0.0111	0.0172	CcSEcCtD
Methylscopolamine bromide—Tension—Nicotine—ulcerative colitis	0.011	0.0169	CcSEcCtD
Methylscopolamine bromide—Nervousness—Nicotine—ulcerative colitis	0.0109	0.0168	CcSEcCtD
Methylscopolamine bromide—Palpitations—Nicotine—ulcerative colitis	0.00988	0.0153	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Nicotine—ulcerative colitis	0.0093	0.0144	CcSEcCtD
Methylscopolamine bromide—Confusional state—Nicotine—ulcerative colitis	0.0092	0.0142	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Nicotine—ulcerative colitis	0.00912	0.0141	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Mesalazine—ulcerative colitis	0.00904	0.014	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Nicotine—ulcerative colitis	0.0089	0.0138	CcSEcCtD
Methylscopolamine bromide—Insomnia—Nicotine—ulcerative colitis	0.00825	0.0127	CcSEcCtD
Methylscopolamine bromide—Somnolence—Nicotine—ulcerative colitis	0.00811	0.0125	CcSEcCtD
Methylscopolamine bromide—Constipation—Nicotine—ulcerative colitis	0.0078	0.0121	CcSEcCtD
Methylscopolamine bromide—Tension—Budesonide—ulcerative colitis	0.00755	0.0117	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Nicotine—ulcerative colitis	0.00752	0.0116	CcSEcCtD
Methylscopolamine bromide—Nervousness—Budesonide—ulcerative colitis	0.00748	0.0116	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Budesonide—ulcerative colitis	0.00725	0.0112	CcSEcCtD
Methylscopolamine bromide—Urticaria—Nicotine—ulcerative colitis	0.00725	0.0112	CcSEcCtD
Methylscopolamine bromide—Scopolamine—ABCB1—ulcerative colitis	0.00714	0.0481	CrCbGaD
Methylscopolamine bromide—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.00693	0.0107	CcSEcCtD
Methylscopolamine bromide—Palpitations—Budesonide—ulcerative colitis	0.0068	0.0105	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Nicotine—ulcerative colitis	0.00672	0.0104	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisolone—ulcerative colitis	0.00658	0.0102	CcSEcCtD
Methylscopolamine bromide—Asthenia—Nicotine—ulcerative colitis	0.00654	0.0101	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Hydrocortisone—ulcerative colitis	0.00643	0.00994	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Budesonide—ulcerative colitis	0.00641	0.0099	CcSEcCtD
Methylscopolamine bromide—Confusional state—Budesonide—ulcerative colitis	0.00633	0.00979	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Budesonide—ulcerative colitis	0.00628	0.00971	CcSEcCtD
Methylscopolamine bromide—Tension—Mesalazine—ulcerative colitis	0.00614	0.00949	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Budesonide—ulcerative colitis	0.00613	0.00947	CcSEcCtD
Methylscopolamine bromide—Nervousness—Mesalazine—ulcerative colitis	0.00608	0.00939	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Triamcinolone—ulcerative colitis	0.00606	0.00936	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Methylprednisolone—ulcerative colitis	0.00604	0.00934	CcSEcCtD
Methylscopolamine bromide—Dizziness—Nicotine—ulcerative colitis	0.00603	0.00932	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mercaptopurine—ulcerative colitis	0.00598	0.00925	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Mesalazine—ulcerative colitis	0.0059	0.00912	CcSEcCtD
Methylscopolamine bromide—Vomiting—Nicotine—ulcerative colitis	0.0058	0.00896	CcSEcCtD
Methylscopolamine bromide—Headache—Nicotine—ulcerative colitis	0.00571	0.00883	CcSEcCtD
Methylscopolamine bromide—Insomnia—Budesonide—ulcerative colitis	0.00568	0.00878	CcSEcCtD
Methylscopolamine bromide—Nausea—Mercaptopurine—ulcerative colitis	0.00559	0.00864	CcSEcCtD
Methylscopolamine bromide—Somnolence—Budesonide—ulcerative colitis	0.00558	0.00863	CcSEcCtD
Methylscopolamine bromide—Palpitations—Mesalazine—ulcerative colitis	0.00553	0.00855	CcSEcCtD
Methylscopolamine bromide—Nausea—Nicotine—ulcerative colitis	0.00542	0.00837	CcSEcCtD
Methylscopolamine bromide—Constipation—Budesonide—ulcerative colitis	0.00537	0.0083	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Mesalazine—ulcerative colitis	0.00521	0.00805	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Budesonide—ulcerative colitis	0.00518	0.008	CcSEcCtD
Methylscopolamine bromide—Confusional state—Mesalazine—ulcerative colitis	0.00515	0.00796	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00511	0.00789	CcSEcCtD
Methylscopolamine bromide—Urticaria—Budesonide—ulcerative colitis	0.00499	0.00771	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Mesalazine—ulcerative colitis	0.00499	0.0077	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisone—ulcerative colitis	0.00478	0.00739	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Budesonide—ulcerative colitis	0.00463	0.00715	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Azathioprine—ulcerative colitis	0.00462	0.00714	CcSEcCtD
Methylscopolamine bromide—Insomnia—Mesalazine—ulcerative colitis	0.00462	0.00714	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mesalazine—ulcerative colitis	0.00454	0.00702	CcSEcCtD
Methylscopolamine bromide—Asthenia—Budesonide—ulcerative colitis	0.00451	0.00696	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Prednisone—ulcerative colitis	0.00438	0.00676	CcSEcCtD
Methylscopolamine bromide—Constipation—Mesalazine—ulcerative colitis	0.00437	0.00675	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—ulcerative colitis	0.00429	0.00664	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mesalazine—ulcerative colitis	0.00421	0.0065	CcSEcCtD
Methylscopolamine bromide—Dizziness—Budesonide—ulcerative colitis	0.00415	0.00642	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Azathioprine—ulcerative colitis	0.00413	0.00638	CcSEcCtD
Methylscopolamine bromide—Urticaria—Mesalazine—ulcerative colitis	0.00406	0.00627	CcSEcCtD
Methylscopolamine bromide—Vomiting—Budesonide—ulcerative colitis	0.00399	0.00617	CcSEcCtD
Methylscopolamine bromide—Headache—Budesonide—ulcerative colitis	0.00394	0.00608	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Mesalazine—ulcerative colitis	0.00376	0.00582	CcSEcCtD
Methylscopolamine bromide—Nausea—Budesonide—ulcerative colitis	0.00373	0.00577	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—ulcerative colitis	0.00372	0.00575	CcSEcCtD
Methylscopolamine bromide—Dizziness—Azathioprine—ulcerative colitis	0.00371	0.00573	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mesalazine—ulcerative colitis	0.00367	0.00566	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.00363	0.00561	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—ulcerative colitis	0.00363	0.00561	CcSEcCtD
Methylscopolamine bromide—Vomiting—Azathioprine—ulcerative colitis	0.00357	0.00551	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Hydrocortisone—ulcerative colitis	0.00355	0.00548	CcSEcCtD
Methylscopolamine bromide—Headache—Azathioprine—ulcerative colitis	0.00351	0.00543	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—ulcerative colitis	0.00349	0.00539	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methylprednisolone—ulcerative colitis	0.00344	0.00532	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.00342	0.00529	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.00341	0.00527	CcSEcCtD
Methylscopolamine bromide—Dizziness—Mesalazine—ulcerative colitis	0.00338	0.00522	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—ulcerative colitis	0.00336	0.0052	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—ulcerative colitis	0.00334	0.00516	CcSEcCtD
Methylscopolamine bromide—Nausea—Azathioprine—ulcerative colitis	0.00333	0.00515	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Methylprednisolone—ulcerative colitis	0.00333	0.00515	CcSEcCtD
Methylscopolamine bromide—Insomnia—Hydrocortisone—ulcerative colitis	0.00329	0.00508	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mesalazine—ulcerative colitis	0.00325	0.00502	CcSEcCtD
Methylscopolamine bromide—Headache—Mesalazine—ulcerative colitis	0.0032	0.00495	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—ulcerative colitis	0.00312	0.00482	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—ulcerative colitis	0.0031	0.0048	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.0031	0.0048	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—ulcerative colitis	0.00309	0.00478	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methylprednisolone—ulcerative colitis	0.00309	0.00477	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—ulcerative colitis	0.00306	0.00474	CcSEcCtD
Methylscopolamine bromide—Nausea—Mesalazine—ulcerative colitis	0.00303	0.00469	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—ulcerative colitis	0.00303	0.00468	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—ulcerative colitis	0.00303	0.00468	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00299	0.00463	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—ulcerative colitis	0.00295	0.00457	CcSEcCtD
Methylscopolamine bromide—Urticaria—Hydrocortisone—ulcerative colitis	0.00289	0.00446	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—ulcerative colitis	0.00282	0.00436	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00281	0.00435	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—ulcerative colitis	0.00281	0.00434	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—ulcerative colitis	0.00281	0.00434	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—ulcerative colitis	0.00274	0.00423	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—ulcerative colitis	0.00272	0.0042	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methylprednisolone—ulcerative colitis	0.00271	0.00419	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—ulcerative colitis	0.0027	0.00418	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.00268	0.00414	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—ulcerative colitis	0.00264	0.00408	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydrocortisone—ulcerative colitis	0.00261	0.00403	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—ulcerative colitis	0.00256	0.00395	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00256	0.00395	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—ulcerative colitis	0.00252	0.00389	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.00251	0.00389	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—ulcerative colitis	0.00247	0.00381	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—ulcerative colitis	0.00247	0.00381	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—ulcerative colitis	0.00246	0.0038	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—ulcerative colitis	0.00245	0.00379	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methylprednisolone—ulcerative colitis	0.00245	0.00378	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—ulcerative colitis	0.00244	0.00378	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydrocortisone—ulcerative colitis	0.0024	0.00371	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—ulcerative colitis	0.00233	0.0036	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—ulcerative colitis	0.00231	0.00357	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydrocortisone—ulcerative colitis	0.00231	0.00357	CcSEcCtD
Methylscopolamine bromide—Headache—Hydrocortisone—ulcerative colitis	0.00228	0.00352	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—ulcerative colitis	0.00226	0.0035	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methylprednisolone—ulcerative colitis	0.00226	0.00349	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—ulcerative colitis	0.00223	0.00344	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—ulcerative colitis	0.00223	0.00344	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—ulcerative colitis	0.00223	0.00344	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—ulcerative colitis	0.00221	0.00341	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—ulcerative colitis	0.00217	0.00336	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methylprednisolone—ulcerative colitis	0.00217	0.00335	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydrocortisone—ulcerative colitis	0.00216	0.00333	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—ulcerative colitis	0.00215	0.00332	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—ulcerative colitis	0.00214	0.00331	CcSEcCtD
Methylscopolamine bromide—Headache—Methylprednisolone—ulcerative colitis	0.00214	0.0033	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—ulcerative colitis	0.00205	0.00317	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—ulcerative colitis	0.00205	0.00317	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—ulcerative colitis	0.00203	0.00314	CcSEcCtD
Methylscopolamine bromide—Nausea—Methylprednisolone—ulcerative colitis	0.00203	0.00313	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—ulcerative colitis	0.00199	0.00308	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—ulcerative colitis	0.00197	0.00305	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—ulcerative colitis	0.00197	0.00305	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—ulcerative colitis	0.00194	0.003	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—ulcerative colitis	0.00194	0.003	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—ulcerative colitis	0.00194	0.003	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—ulcerative colitis	0.00184	0.00285	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—ulcerative colitis	0.00184	0.00285	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—ulcerative colitis	0.00179	0.00276	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—ulcerative colitis	0.00172	0.00266	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—ulcerative colitis	0.00169	0.00262	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—ulcerative colitis	0.00161	0.00248	CcSEcCtD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000623	0.00305	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCR2—ulcerative colitis	0.00062	0.00303	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000617	0.00302	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000604	0.00295	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000602	0.00294	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000596	0.00291	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCR6—ulcerative colitis	0.00059	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCR6—ulcerative colitis	0.000589	0.00288	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCR1—ulcerative colitis	0.000585	0.00286	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCR6—ulcerative colitis	0.000583	0.00285	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCL20—ulcerative colitis	0.000566	0.00276	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—ADRB2—ulcerative colitis	0.00056	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000545	0.00267	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GNA12—ulcerative colitis	0.000532	0.0026	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000525	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00052	0.00254	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—PTGER4—ulcerative colitis	0.000518	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000517	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000516	0.00252	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL20—ulcerative colitis	0.000514	0.00251	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—PTGER4—ulcerative colitis	0.000513	0.00251	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000511	0.0025	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000504	0.00246	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GNA12—ulcerative colitis	0.000483	0.00236	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—GHRL—ulcerative colitis	0.000476	0.00233	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—GHRL—ulcerative colitis	0.000474	0.00232	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCR6—ulcerative colitis	0.000474	0.00232	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—GHRL—ulcerative colitis	0.00047	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—PPARG—ulcerative colitis	0.000467	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCR2—ulcerative colitis	0.000458	0.00224	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000454	0.00222	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000452	0.00221	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000448	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CHP1—ulcerative colitis	0.000443	0.00217	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000431	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCR6—ulcerative colitis	0.00043	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SEL1L—ulcerative colitis	0.00042	0.00205	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000417	0.00204	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000413	0.00202	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000412	0.00201	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCR1—ulcerative colitis	0.000411	0.00201	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCR1—ulcerative colitis	0.000407	0.00199	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000398	0.00195	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCL20—ulcerative colitis	0.000397	0.00194	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000394	0.00193	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCL20—ulcerative colitis	0.000393	0.00192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—ADRB2—ulcerative colitis	0.000393	0.00192	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—ADRB2—ulcerative colitis	0.000389	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000385	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—DLD—ulcerative colitis	0.000383	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GHRL—ulcerative colitis	0.000382	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PTGER4—ulcerative colitis	0.000379	0.00185	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000374	0.00183	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GNA12—ulcerative colitis	0.000373	0.00182	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.00037	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GNA12—ulcerative colitis	0.00037	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000369	0.0018	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL20—ulcerative colitis	0.000362	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL20—ulcerative colitis	0.00036	0.00176	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL20—ulcerative colitis	0.000357	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000355	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000355	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000354	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00035	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GHRL—ulcerative colitis	0.000347	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCR1—ulcerative colitis	0.000346	0.00169	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GNA12—ulcerative colitis	0.00034	0.00166	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GNA12—ulcerative colitis	0.000339	0.00166	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CALM3—ulcerative colitis	0.000336	0.00164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GNA12—ulcerative colitis	0.000336	0.00164	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000334	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR6—ulcerative colitis	0.000333	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR6—ulcerative colitis	0.000329	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000322	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCR2—ulcerative colitis	0.000321	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCR2—ulcerative colitis	0.000318	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000316	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00031	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL20—ulcerative colitis	0.000303	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR6—ulcerative colitis	0.000303	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR6—ulcerative colitis	0.000302	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.0003	0.00147	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR6—ulcerative colitis	0.000299	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SEL1L—ulcerative colitis	0.000295	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SEL1L—ulcerative colitis	0.000295	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000294	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000293	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SEL1L—ulcerative colitis	0.000292	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00029	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRB2—ulcerative colitis	0.000287	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GNA12—ulcerative colitis	0.000285	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCR2—ulcerative colitis	0.00027	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CXCL8—ulcerative colitis	0.00027	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000269	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000269	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000268	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GHRL—ulcerative colitis	0.000268	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000267	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTGER4—ulcerative colitis	0.000266	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GHRL—ulcerative colitis	0.000266	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTGER4—ulcerative colitis	0.000263	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR6—ulcerative colitis	0.000254	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00025	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000249	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000247	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GHRL—ulcerative colitis	0.000244	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADCY5—ulcerative colitis	0.000244	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GHRL—ulcerative colitis	0.000243	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCR1—ulcerative colitis	0.000243	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCR1—ulcerative colitis	0.000243	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000242	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GHRL—ulcerative colitis	0.000241	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAML2—ulcerative colitis	0.000241	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCR1—ulcerative colitis	0.00024	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CALM3—ulcerative colitis	0.000237	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CALM3—ulcerative colitis	0.000236	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	0.000234	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTGER4—ulcerative colitis	0.000224	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000223	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000222	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00022	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	0.000219	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	0.000214	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL20—ulcerative colitis	0.000213	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	0.000211	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GHRL—ulcerative colitis	0.000205	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000202	0.000988	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRB2—ulcerative colitis	0.000202	0.000985	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	0.000201	0.000982	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNA12—ulcerative colitis	0.0002	0.000979	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	0.0002	0.000978	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	0.0002	0.000976	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CALM3—ulcerative colitis	0.000198	0.00097	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	0.000198	0.000969	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RIPK2—ulcerative colitis	0.000195	0.000956	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	0.00019	0.000931	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	0.00019	0.00093	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCR2—ulcerative colitis	0.00019	0.000928	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCL8—ulcerative colitis	0.00019	0.000927	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.00019	0.000927	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000189	0.000924	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000189	0.000924	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000188	0.000921	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	0.000188	0.000919	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	0.000188	0.000918	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000187	0.000912	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS1—ulcerative colitis	0.000185	0.000904	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	0.000179	0.000875	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR6—ulcerative colitis	0.000178	0.000872	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	0.000177	0.000864	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000172	0.000839	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADCY5—ulcerative colitis	0.000171	0.000836	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	0.00017	0.00083	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRB2—ulcerative colitis	0.00017	0.000829	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	0.000169	0.000828	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAML2—ulcerative colitis	0.000169	0.000827	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	0.000168	0.000819	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—JAK2—ulcerative colitis	0.000167	0.000818	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CALM3—ulcerative colitis	0.000167	0.000814	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	0.000158	0.00077	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTGER4—ulcerative colitis	0.000157	0.000768	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	0.000156	0.00076	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000153	0.000747	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—JAK2—ulcerative colitis	0.000152	0.000743	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL2—ulcerative colitis	0.000146	0.000713	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	0.000144	0.000705	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADCY5—ulcerative colitis	0.000144	0.000704	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GHRL—ulcerative colitis	0.000144	0.000703	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	0.000142	0.000696	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	0.00014	0.000683	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CALM3—ulcerative colitis	0.000139	0.000681	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL8—ulcerative colitis	0.000139	0.000678	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	0.000138	0.000674	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	0.000138	0.000673	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RIPK2—ulcerative colitis	0.000137	0.000671	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	0.000136	0.000664	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL2—ulcerative colitis	0.000133	0.000648	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCB1—ulcerative colitis	0.00013	0.000633	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADCY5—ulcerative colitis	0.000121	0.000591	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	0.000119	0.000584	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRB2—ulcerative colitis	0.000119	0.000582	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	0.000118	0.000576	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000118	0.000576	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—JAK2—ulcerative colitis	0.000117	0.000574	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	0.000116	0.000569	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000108	0.000526	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000107	0.000524	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	0.000107	0.000523	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—JAK2—ulcerative colitis	0.000107	0.000521	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000106	0.000519	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	0.000106	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	0.000103	0.000502	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—ulcerative colitis	0.000102	0.000501	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	0.000101	0.000496	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	0.000101	0.000496	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADCY5—ulcerative colitis	0.000101	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	0.0001	0.000489	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	9.76e-05	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—ulcerative colitis	9.73e-05	0.000476	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	9.64e-05	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	9.33e-05	0.000456	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—ulcerative colitis	9.3e-05	0.000455	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	9.21e-05	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—ulcerative colitis	9.01e-05	0.000441	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JAK2—ulcerative colitis	8.98e-05	0.000439	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RELA—ulcerative colitis	8.69e-05	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	8.19e-05	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—ulcerative colitis	8.1e-05	0.000396	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—ulcerative colitis	7.83e-05	0.000383	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	7.79e-05	0.000381	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	7.41e-05	0.000362	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	7.33e-05	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—ulcerative colitis	7.09e-05	0.000347	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	6.59e-05	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	6.32e-05	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	6.3e-05	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	6.24e-05	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RELA—ulcerative colitis	6.12e-05	0.000299	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	6.11e-05	0.000299	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RELA—ulcerative colitis	6.1e-05	0.000298	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RELA—ulcerative colitis	6.04e-05	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	5.77e-05	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	5.75e-05	0.000281	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	5.69e-05	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—ulcerative colitis	5.51e-05	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—ulcerative colitis	5.5e-05	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	5.49e-05	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	5.47e-05	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—ulcerative colitis	5.44e-05	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	5.41e-05	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	5.22e-05	0.000255	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	5.2e-05	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	5.16e-05	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	5.15e-05	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	5.15e-05	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	5.1e-05	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—ulcerative colitis	5.03e-05	0.000246	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	4.64e-05	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	4.62e-05	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—ulcerative colitis	4.6e-05	0.000225	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	4.58e-05	0.000224	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.3e-05	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	4.29e-05	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	4.24e-05	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—ulcerative colitis	3.54e-05	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—ulcerative colitis	3.53e-05	0.000172	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—ulcerative colitis	3.49e-05	0.000171	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—ulcerative colitis	3.24e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—ulcerative colitis	3.23e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—ulcerative colitis	3.2e-05	0.000156	CbGpPWpGaD
